The agentic AI-augmented Living-DST annotated 1,997 oncology trials 99% faster than humans with >90% accuracy, outperforming other AI tools in evidence completeness and precision.
An agentic AI system can accurately and rapidly extract clinical trial data from oncology literature, significantly reducing the time required for systematic literature reviews compared to human experts.
Absolute Event Rate: 0% vs 0%
Abstract Background: Oncologists face growing difficulty in staying current with rapidly evolving data from congresses, journals, guidelines, and regulatory updates. Creating a well-organized, annotated clinical trial (CT) data library in an easily digestible format is time- and labor-intensive. To address this, we developed and validated a living-DST for breast cancer (BC), powered by an agentic AI system that supports daily human conducted / AI augmented SLR integrated with guidelines, regulatory approvals and ongoing CT results. Methods: An agentic AI system using GPT-4.1 2025 Dec 9-12; San Antonio, TX. Philadelphia (PA): AACR; Clin Cancer Res 2026;32(4 Suppl):Abstract nr PS3-04-10.
Schwartzberg et al. (Tue,) ont rapporté un autre. L'IA agentique augmentée Living-DST a annoté 1 997 essais oncologiques 99 % plus rapidement que les humains avec une précision de >90 %, surpassant d'autres outils d'IA en termes de complétude et de précision des preuves.